New study aims to keep HIV at bay with easier prevention options
NCT ID NCT07221747
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 29 times
Summary
This study looks at ways to help people in Malawi keep taking their HIV prevention medicine, including a new long-acting shot that is given every two months. About 9,900 people at high risk for HIV will take part. The goal is to see if extra support helps them stay on the medication without gaps.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL PRE-EXPOSURE PROPHYLAXIS (PREP) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Community Health Science Unit
RECRUITINGLilongwe, Malawi
Contact
Conditions
Explore the condition pages connected to this study.